Theranostics has just received its latest Impact Factor for the year 2022, which is 12.4. It ranks 8th among 136 comprehensive journals worldwide in the field of medical research and experimental studies, placing it in the top tier of JCR Q1. Congratulations!
Theranostics journal is dedicated to integrated research in clinical and basic medicine. It primarily publishes articles and review papers on molecular diagnostics in vivo and in vitro, tumor treatment, targeted therapy, biological therapy, nanomedicine, translational medicine, as well as basic biomedical research. Welcome to submit your manuscript to Theranostics.
